v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Dec. 31, 2024
Current Assets:      
Cash and cash equivalents $ 670,488 $ 459,174 $ 34,085
Prepaid expenses and other current assets 310,964 159,985 11,454
Total Current Assets 981,452 619,159 45,539
Non-Current Assets:      
Deferred equity issuance costs   193,876
Total Assets 981,452 619,159 239,415
Current Liabilities:      
Accounts payable - trade 1,674,005 1,512,090 1,361,081
Accrued expenses 810,589 596,465 1,049,910
Financing liability 162,208  
Accrued interest   134,875
Convertible notes payable, net of debt issuance costs and discounts   1,248,708
Derivative liability arising from convertible notes payable   544,957
Total Current Liabilities 2,646,802 2,108,555 4,339,531
Total Liabilities 2,646,802 2,108,555 4,339,531
Commitments and contingencies (Note 12)
Stockholders’ Deficit:      
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value; 50,000,000 shares authorized; 9,053,279 and 8,655,829 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 905 866 [1] 325 [1]
Additional paid-in capital 9,976,954 7,801,539 23,791
Accumulated deficit (11,643,209) (9,291,801) (4,124,232)
Total Stockholders’ Deficit (1,665,350) (1,489,396) (4,100,116)
Total Liabilities and Stockholders’ Deficit $ 981,452 $ 619,159 $ 239,415
[1] The number of shares and per share value of the Company’s common stock have been retroactively recast to reflect the exchange ratio pursuant to the Merger (see Note 3).